CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Dignitana AB Company Snapshot
Dignitana AB operates within the Electromedical equipment sector. In addition to historical fundamental analyses, the complete report available to purchase compares Dignitana AB with three other companies in this sector in Sweden: Glycorex Transplantation AB (publ) (2017 sales of 29.56 million Swedish Kronor [US$3.25 million] ), LifeAssays AB (publ) (7.10 million Swedish Kronor [US$781,827.21 ] ), and Cellink AB (13.19 million Swedish Kronor [US$1.45 million] ).

Sales Analysis. Sales increased substantially in 2017: During the year ended December of 2017, sales at Dignitana AB were SEK 22.94 million (US$2.53 million). This is an increase of 157.7% versus 2016, when the company's sales were SEK 8.90 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Dignitana AB
  Stock Performance Chart for Dignitana AB
 
  Stock Data: Recent Stock Performance:
  Current Price (11/16/2018): 5.38
(Figures in Swedish Kronor)
1 Week -12.4%   13 Weeks -12.7%  
4 Weeks 32.5%   52 Weeks 143.8%  
 
Dignitana AB Key Data:
  Ticker: DIGN Country: Sweden
  Exchanges: STO Major Industry: Health Care Equipment & Services
    Sub Industry: Electromedical Equipment
  2017 Sales 22,941,000
(Year Ending Jan 2018).
Employees: 9
  Currency: Swedish Kronor Market Cap: 218,149,445
  Fiscal Yr Ends: December Shares Outstanding: 40,548,224
  Share Type: Closely Held Shares:
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.